Keeping It Real: Communicating Authentically About Diversity, Equity And Inclusion
• By Ben Comer
In Vivo’s 2021 Rising Leader Alvine Tremoulet favored backroads over the corporate highway en route to her current position as global diversity, equity and inclusion lead at Pfizer. Tremoulet’s background in communications, and a strong network of female leaders, helped her to successfully influence internal and external stakeholders on issues still considered taboo in many parts of the world.
A look at Novo Nordisk, Eli Lilly and other companies' late-stage clinical studies of GLP-1 drugs in indications ranging from neurodegeneration to oncology, and alcoholic liver disease to autoimmune conditions.
Metsera CEO Whit Bernard applies an unconventional leadership philosophy to develop next-generation obesity therapeutics, including monthly GLP-1 injections and oral peptides.
Advanced AI is revolutionizing sales enablement by addressing training gaps and performance challenges. Used correctly, it can help to bridge the sales-marketing divide, accelerate ramp-up times and provide managers with data-driven insights.
Flagship Pioneering senior partner Raj Panjabi discusses shifting health care from reactive treatment to AI-powered prediction and prevention of disease before symptoms emerge.
Namrata Saroj, chief business officer of Ocular Therapeutix, is highly respected in the retina community for her contributions to drug development. She talked to In Vivo about her journey in ophthalmology, leadership philosophy and the importance of authenticity in a close-knit specialty.